Company: VCYT
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001384101-25-000130
Chunk: 90

Company: VERACYTE, INC.
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 8
Chunk 90
---
 research and development expense3,512 5,479 10,946 14,596 Other research and development expenses (4)1,586 1,338 5,278 4,195 Allocation of facilities and IT expenses1,855 1,851 5,901 4,857 Total research and development15,981 17,574 49,965 50,004 Selling and marketing:Compensation expense16,977 15,814 52,214 50,517 Direct marketing expense1,376 1,427 3,564 4,613 Other selling and marketing expenses (5)3,332 3,271 10,880 9,897 Allocation of facilities and IT expenses2,770 2,100 7,567 5,583 Total selling and marketing24,455 22,612 74,225 70,610 General and administrative:Compensation expense20,688 18,958 62,121 59,824 Other general and administrative expenses (6)14,508 14,565 56,132 45,048 Allocation of facilities and IT expenses(7,918)(7,781)(24,836)(21,175)Total general and administrative27,278 25,742 93,417 83,697 Impairment of assets— 185 20,505 614 Intangible asset amortization - operating expenses622 880 1,865 2,499 Other income, net4,057 (4,831)(6,985)(10,334)Income tax (benefit) provision(248)1,693 2,363 3,276 Net income$19,137 $15,155 $25,204 $19,025 

20

________________(1)Other cost of testing revenue includes cytopathology services, depreciation and amortization and other expenses.(2)Other cost of product revenue includes contract manufacturing fees, license fees and royalties, depreciation and amortization and other expenses.(3)Other cost of biopharmaceutical and other revenue includes license fees and royalties, depreciation and amortization and other expenses.(4)Other research and development expenses includes depreciation and amortization and other expenses.(5)Other selling and marketing expenses includes travel, entertainment, conference and other expenses.(6)Other general and administrative expenses includes professional fees, information technology expense, occupancy